Results 231 to 240 of about 921,415 (254)

No Observable Adverse Effect Level (NoAEL)

2015
openaire   +1 more source

Determining the No-Observed-Adverse-Effect Level in Continuous Response

1993
Yasuki Kikuchi, Takashi Yanagawa, Harutoshi Nishiyama   +2 more
openaire   +1 more source

Predicting adverse drug reactions

Nature Reviews Drug Discovery, 2012
Harrison Charlotte
exaly  

Statistical uncertainty in the no-observed-adverse-effect level*1

Fundamental and Applied Toxicology, 1989
openaire   +1 more source

Does adjuvant ipilimumab have little adverse effect on quality of life?

Nature Reviews Clinical Oncology, 2017
Adele Green, Paul Lorigan, Lorigan Paul   +2 more
exaly  

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Nature Reviews Clinical Oncology, 2019
Solange Peters, Camillo Ribi, John Thompson   +2 more
exaly  

Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C

Nature Reviews Gastroenterology and Hepatology, 2011
Markus Peck-Radosavljevic, Mark Sulkowski, Curtis Cooper   +2 more
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata Tarifa, Joyce Slingerland   +1 more
exaly  

Managing adverse effects and drug–drug interactions of antiplatelet agents

Nature Reviews Cardiology, 2011
, Lincoff A Michael
exaly  

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials

JAMA Oncology, 2019
Steve Ansell, Thorvardur Halfdanarson, Yucai Wang   +2 more
exaly